TYRA
TYRA
US90240B1061
Tyra Biosciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
132.762.000 104.177.000
27.4%
Operating Income -132.762.000 -104.177.000
27.4%
Pretax Income -119.947.000 -86.481.000
38.7%
Net Income Common Stockholders -119.947.000 -86.481.000
38.7%
-- --
--
-- --
--
ende